The Hormel Institute Buys IBM Supercomputer As it Expands Role, Scope of Research

The Hormel Institute, a medical research unit of the University of Minnesota, and IBM (NYSE: IBM) today announced the Institute will become the first research laboratory in the state to employ the world’s most powerful supercomputer design, the IBM Blue Gene.
The Institute’s acquisition of a Blue Gene supercomputer is part of a multi-year expansion for the facility. The expansion and the new computer will allow the Institute – recognized worldwide for its leading-edge cancer research — to triple the amount of projects it undertakes.

Dr. Zigang Dong, M.D., Dr. P.H., executive director of The Hormel Institute and Mike Good, Blue Gene program manager for IBM in Minnesota collaborate to install the first Blue Gene supercomputer in the state of Minnesota at The Hormel Institute, a medical research unit of the University of Minnesota, in Austin, Minn.

‘‘Blue Gene will allow The Hormel Institute to accelerate cancer research and advance the field of research technology,” said Dr. Zigang Dong, M.D., Dr. P.H., executive director of The Hormel Institute. “The expansion of space and talent, combined with providing the most cutting edge technology available in the world, will propel The Hormel Institute to the next level of scientific achievement.”

Read the complete Press Release